Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy R. YangH. DongZ. Yang Review Article 17 January 2022 Pages: 1219 - 1230
Platelets for cancer treatment and drug delivery Gaozhe XiaoZhikun ZhangJian He Review Article 26 February 2022 Pages: 1231 - 1237
Emerging roles of JMJD3 in cancer Maryam FarzanehZeinab KuchakiOmid Anbiyaee Review Article 03 March 2022 Pages: 1238 - 1249
The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML Shohre Karimi KelayeFatemeh NajafiMohammad-Reza Alivand Review Article 25 January 2022 Pages: 1250 - 1261
Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors Nada K. SedkyAlyaa A. HamdanMai F. Tolba Review Article 23 January 2022 Pages: 1262 - 1273
The role of EphA7 in different tumors Xiangyi ChenDechen YuKun Zhang Review Article 02 February 2022 Pages: 1274 - 1289
Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer J. Orcajo-RinconJ. Muñoz-LangaA. Luna Special Article Open access 13 February 2022 Pages: 1290 - 1310
MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2 L. LiuB. GuoS. Liu Research Article 05 February 2022 Pages: 1311 - 1321
RENORT: a project to analyze patterns of care in radiation oncology in Spain J. López-TorrecillaA. Palacios EitoA. Rodríguez Pérez Research Article 13 January 2022 Pages: 1322 - 1332
Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents Chuanzhen CaoXiaomei LanJianzhong Shou Research Article Open access 03 February 2022 Pages: 1333 - 1346
Comparison of postoperative complication rates between a novel endoluminal balloon-assisted drainage and diverting stoma after low rectal cancer W. LiangH. JieL. Kang Research Article 14 January 2022 Pages: 1347 - 1353
Cytokine-driven positive feedback loop organizes fibroblast transformation and facilitates gastric cancer progression Xian-Kui CaoBin XieJie Lin Research Article 18 March 2022 Pages: 1354 - 1364
Identification of the function of γδ1 T cells in the lung cancer microenvironments W. SunH. YangC. Ma Research Article 29 January 2022 Pages: 1365 - 1371
Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia Fatemeh MemariVahid TavakolpourNosratollah Zarghami Research Article 05 March 2022 Pages: 1372 - 1380
A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer Zicheng WangYifei ZhangBinbin Gong Research Article 10 February 2022 Pages: 1381 - 1394
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer M. LoiG. SalvatoreL. Livi Research Article 25 February 2022 Pages: 1395 - 1402
Autophagy deficiency promotes lung metastasis of prostate cancer via stabilization of TWIST1 Y. X. ShiZ. W. SunH. B. Wang Research Article 08 February 2022 Pages: 1403 - 1412
RNA modification “writer”-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer Yanjun QuHong ZhuDandan Yuan Research Article 27 February 2022 Pages: 1413 - 1424
Radiotherapy-related toxicity for localized prostate cancer: meta-analysis comparing conventional or moderately hypofractionated vs. ultrahypofractionated protocols Willy BaccagliniIcaro T. de CarvalhoSidney Glina Research Article 04 March 2022 Pages: 1425 - 1439
Assessing the tumor immune microenvironment in gastric carcinoma: a practical approach H. AbushukairA. Saeed Correspondence 02 February 2022 Pages: 1440 - 1441
Correction to: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021) Margarita MajemRamon de las PeñasYolanda Escobar Correction Open access 14 May 2022 Pages: 1442 - 1442
Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021) Jaume CapdevilaMa Auxiliadora GómezJavier Sastre Correction Open access 20 May 2022 Pages: 1443 - 1444
Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer Takatoshi EnomotoAkihiro TamiyaShinji Atagi Correction 22 February 2022 Pages: 1445 - 1445